Loteprednol Etabonate Gel
Product Images NDC 72485-630

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Loteprednol Etabonate (NDC 72485-630). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Armas Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lot01 0005 01)

Chemical structure of Loteprednol Etabonate with molecular weight 466.96, showing its detailed steroidal framework and functional groups.*

FDA Label Image

Carton (Loteprednol Gel 0.5 5 Carton)

Packaging label for Loteprednol Etabonate Ophthalmic Gel 0.5%, an eye gel in a 5 g container. The label features the active ingredient Loteprednol Etabonate at 5 mg/g, with additional inactive ingredients and a preservative listed. It includes directions for storage, usage warnings, and identification marks, with distribution by Armas Pharmaceuticals Inc. and manufacturing in Switzerland for Sentiss.*

FDA Label Image

Container (Loteprednol Gel 0.5 5 G Container)

Loteprednol Etabonate Ophthalmic Gel 0.5% label with active ingredient Loteprednol Etabonate 5 mg per gram. The sterile gel is for use in the eyes only, packaged in a 5 gram container. Distributed by Armas Pharmaceuticals, Inc., Freehold, NJ, made in Switzerland. Includes storage instructions and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.